Authors: MARK HFL PRZYGODA JJ SIKOV W

Citation: Hfl. Mark et al., FLUORESCENT IN-SITU HYBRIDIZATION FOR IDENTIFYING CYTOGENETIC ABNORMALITIES IN INADEQUATE AND SUBOPTIMAL SPECIMENS, Pathobiology, 66(5), 1998, pp. 216-220

Authors: SAFRAN H KING TP CHOY H HESKETH PJ WOLF B ALTENHEIN E SIKOV W ROSMARIN A AKERLEY W RADIEKEANE K CICCHETTI G LOPEZ F BLAND K WANEBO HJ

Citation: H. Safran et al., PACLITAXEL AND CONCURRENT RADIATION FOR LOCALLY ADVANCED PANCREATIC AND GASTRIC-CANCER - G PHASE-I STUDY, Journal of clinical oncology, 15(3), 1997, pp. 901-907

Authors: AKERLEY W CHOY H SAFRAN H SIKOV W REGE V SAMBANDAM S WITTELS E

Citation: W. Akerley et al., WEEKLY PACLITAXEL IN PATIENTS WITH ADVANCED LUNG-CANCER - PRELIMINARYDATA FROM A PHASE-II TRIAL, Seminars in oncology, 24(4), 1997, pp. 10-13

Authors: CLARK J SIKOV W CUMMINGS F BROWN M AKERLEY W WANEBO H WEITBERG A KENNEDY T COLE B BIGLEY J BEITZ J DARNOWSKI J

Citation: J. Clark et al., PHASE-II STUDY OF 5-FLUORURACIL LEUCOVORIN AND AZIDOTHYMIDINE IN PATIENTS WITH METASTATIC COLORECTAL-CANCER, Journal of cancer research and clinical oncology, 122(9), 1996, pp. 554-558

Authors: MARK HFL SIKOV W SAFRAN H KING TC GRIFFITH RC

Citation: Hfl. Mark et al., FLUORESCENT IN-SITU HYBRIDIZATION FOR ASSESSING THE PROPORTION OF CELLS WITH TRISOMY-4 IN A PATIENT WITH ACUTE NONLYMPHOBLASTIC LEUKEMIA, Annals of clinical and laboratory science, 25(4), 1995, pp. 330-335